+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Alcohol Dehydrogenase Market By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 216 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994260
The alcohol dehydrogenase market was valued at $0.6 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 6.5% from 2024 to 2033.

Alcohol dehydrogenase is class of zinc-containing enzyme that is majorly responsible for the oxidation of alcohols to aldehydes or ketones. This enzyme is predominantly synthesized liver and stomach of humans that acts as a primary defense against a toxic molecule, alcohol. Alcohol dehydrogenase detoxifies this potentially harmful molecule into a mere foodstuff, thereby playing a critical role in preventing the accumulation of toxic levels and eliminating alcohol from the body.

The growth of the global alcohol dehydrogenase market is majorly driven by rise in global alcohol consumption and alarming increase in prevalence of alcohol-related diseases. This is attributed to the fact that alcohol dehydrogenase mitigates the intoxicating effects of alcohol and facilitates its excretion from the body. According to the World Health Organization, alcohol is an established carcinogen and is known to increase the risk of cancer. Approximately 401,000 cancer deaths were registered in 2019 due to alcohol consumption. In addition, rise in awareness about alcohol-related health issues and the need for effective diagnostic tools and treatments boosts the demand for alcohol dehydrogenase. Moreover, increase in adoption of alcohol dehydrogenase in green chemistry notably contributes toward the growth of the market. However, high production cost of alcohol dehydrogenase restrains the growth of the market. Furthermore, the complexity associated with the production process and the need for advanced technology and skilled technicians incur additional costs, which further restrict the market growth. On the contrary, advances in diagnostic technologies, such as more accurate and efficient assays for measuring alcohol dehydrogenase activity, are expected to offer remunerative opportunities for the market growth during the forecast period. Furthermore, technological innovations in biotechnology and enzyme engineering contribute to the development of new alcohol dehydrogenase products and applications, including recombinant alcohol dehydrogenase enzymes and improved diagnostic assays, which are anticipated to open new avenues for the expansion of the market.

The alcohol dehydrogenase industry is segmented into type, application, and region. On the basis of type, the market is bifurcated into medium-chain enzymes and short-chain enzymes. On the basis of application, the market is segregated into alcohol concentration detection, disease diagnosis, and catalyst. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the medium-chain segment dominated the market in 2023.

On the basis of application, the alcohol concentration detection segment held a major share of the market in 2023.

Region wise, North America exhibited the highest growth in 2023.

Competition Analysis

Competitive analysis and profiles of the major players in the global alcohol dehydrogenase market include Sigma-Aldrich, Thermo Fisher Scientific, BioVision Inc., Creative Enzymes Technologies, LLC, MP Biomedicals, Randox Laboratories Limited, Sekisui Diagnostics, Prospec-Tany Technogene Ltd., Roche Diagnostics, and Worthington Biochemical Corporation These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Type

  • Medium-chain Enzymes
  • Short-chain Enzymes

By Application

  • Alcohol Concentration Detection
  • Disease Diagnosis
  • Catalyst

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • BioVision Inc.
  • Creative Enzymes Technologies, LLC
  • MP Biomedicals
  • Randox Laboratories Limited
  • Sekisui Diagnostics
  • Prospec-Tany Technogene Ltd.
  • Roche Diagnostics
  • worthington biochemical corporation

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ALCOHOL DEHYDROGENASE MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Medium-chain Enzymes
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Short-chain Enzymes
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Alcohol Concentration Detection
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Disease Diagnosis
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Catalyst
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: ALCOHOL DEHYDROGENASE MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Type
6.2.3. Market Size and Forecast, By Application
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Alcohol Dehydrogenase Market
6.2.5.1. Market Size and Forecast, By Type
6.2.5.2. Market Size and Forecast, By Application
6.2.6. Canada Alcohol Dehydrogenase Market
6.2.6.1. Market Size and Forecast, By Type
6.2.6.2. Market Size and Forecast, By Application
6.2.7. Mexico Alcohol Dehydrogenase Market
6.2.7.1. Market Size and Forecast, By Type
6.2.7.2. Market Size and Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Type
6.3.3. Market Size and Forecast, By Application
6.3.4. Market Size and Forecast, By Country
6.3.5. France Alcohol Dehydrogenase Market
6.3.5.1. Market Size and Forecast, By Type
6.3.5.2. Market Size and Forecast, By Application
6.3.6. Germany Alcohol Dehydrogenase Market
6.3.6.1. Market Size and Forecast, By Type
6.3.6.2. Market Size and Forecast, By Application
6.3.7. Italy Alcohol Dehydrogenase Market
6.3.7.1. Market Size and Forecast, By Type
6.3.7.2. Market Size and Forecast, By Application
6.3.8. Spain Alcohol Dehydrogenase Market
6.3.8.1. Market Size and Forecast, By Type
6.3.8.2. Market Size and Forecast, By Application
6.3.9. UK Alcohol Dehydrogenase Market
6.3.9.1. Market Size and Forecast, By Type
6.3.9.2. Market Size and Forecast, By Application
6.3.10. Rest Of Europe Alcohol Dehydrogenase Market
6.3.10.1. Market Size and Forecast, By Type
6.3.10.2. Market Size and Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Type
6.4.3. Market Size and Forecast, By Application
6.4.4. Market Size and Forecast, By Country
6.4.5. China Alcohol Dehydrogenase Market
6.4.5.1. Market Size and Forecast, By Type
6.4.5.2. Market Size and Forecast, By Application
6.4.6. Japan Alcohol Dehydrogenase Market
6.4.6.1. Market Size and Forecast, By Type
6.4.6.2. Market Size and Forecast, By Application
6.4.7. India Alcohol Dehydrogenase Market
6.4.7.1. Market Size and Forecast, By Type
6.4.7.2. Market Size and Forecast, By Application
6.4.8. South Korea Alcohol Dehydrogenase Market
6.4.8.1. Market Size and Forecast, By Type
6.4.8.2. Market Size and Forecast, By Application
6.4.9. Australia Alcohol Dehydrogenase Market
6.4.9.1. Market Size and Forecast, By Type
6.4.9.2. Market Size and Forecast, By Application
6.4.10. Rest of Asia-Pacific Alcohol Dehydrogenase Market
6.4.10.1. Market Size and Forecast, By Type
6.4.10.2. Market Size and Forecast, By Application
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Type
6.5.3. Market Size and Forecast, By Application
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Alcohol Dehydrogenase Market
6.5.5.1. Market Size and Forecast, By Type
6.5.5.2. Market Size and Forecast, By Application
6.5.6. South Africa Alcohol Dehydrogenase Market
6.5.6.1. Market Size and Forecast, By Type
6.5.6.2. Market Size and Forecast, By Application
6.5.7. Saudi Arabia Alcohol Dehydrogenase Market
6.5.7.1. Market Size and Forecast, By Type
6.5.7.2. Market Size and Forecast, By Application
6.5.8. Rest of LAMEA Alcohol Dehydrogenase Market
6.5.8.1. Market Size and Forecast, By Type
6.5.8.2. Market Size and Forecast, By Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Sigma-Aldrich
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Thermo Fisher Scientific
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. BioVision Inc.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Creative Enzymes Technologies, LLC
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. MP Biomedicals
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Randox Laboratories Limited
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Sekisui Diagnostics
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Prospec-Tany Technogene Ltd.
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Roche Diagnostics
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Worthington Biochemical Corporation
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 2. ALCOHOL DEHYDROGENASE MARKET FOR MEDIUM-CHAIN ENZYMES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ALCOHOL DEHYDROGENASE MARKET FOR SHORT-CHAIN ENZYMES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GLOBAL ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 5. ALCOHOL DEHYDROGENASE MARKET FOR ALCOHOL CONCENTRATION DETECTION, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ALCOHOL DEHYDROGENASE MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ALCOHOL DEHYDROGENASE MARKET FOR CATALYST, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ALCOHOL DEHYDROGENASE MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. NORTH AMERICA ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 10. NORTH AMERICA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 11. NORTH AMERICA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 12. U.S. ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 13. U.S. ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 14. CANADA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 15. CANADA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. MEXICO ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 17. MEXICO ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 18. EUROPE ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 19. EUROPE ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 20. EUROPE ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 21. FRANCE ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 22. FRANCE ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 23. GERMANY ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 24. GERMANY ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. ITALY ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 26. ITALY ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 27. SPAIN ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 28. SPAIN ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. UK ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 30. UK ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 31. REST OF EUROPE ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 32. REST OF EUROPE ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 33. ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 34. ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 35. ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 36. CHINA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 37. CHINA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 38. JAPAN ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 39. JAPAN ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 40. INDIA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 41. INDIA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 42. SOUTH KOREA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 43. SOUTH KOREA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. AUSTRALIA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 45. AUSTRALIA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 46. REST OF ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 47. REST OF ASIA-PACIFIC ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 48. LAMEA ALCOHOL DEHYDROGENASE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 49. LAMEA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 50. LAMEA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 51. BRAZIL ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 52. BRAZIL ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 53. SOUTH AFRICA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 54. SOUTH AFRICA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 55. SAUDI ARABIA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 56. SAUDI ARABIA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. REST OF LAMEA ALCOHOL DEHYDROGENASE MARKET, BY TYPE, 2024 - 2033 ($BILLION)
TABLE 58. REST OF LAMEA ALCOHOL DEHYDROGENASE MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 59. SIGMA-ALDRICH: KEY EXECUTIVES
TABLE 60. SIGMA-ALDRICH: COMPANY SNAPSHOT
TABLE 61. SIGMA-ALDRICH: OPERATING SEGMENTS
TABLE 62. SIGMA-ALDRICH: PRODUCT PORTFOLIO
TABLE 63. SIGMA-ALDRICH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 64. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
TABLE 65. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 66. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 67. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 68. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. BIOVISION INC.: KEY EXECUTIVES
TABLE 70. BIOVISION INC.: COMPANY SNAPSHOT
TABLE 71. BIOVISION INC.: OPERATING SEGMENTS
TABLE 72. BIOVISION INC.: PRODUCT PORTFOLIO
TABLE 73. BIOVISION INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. CREATIVE ENZYMES TECHNOLOGIES, LLC: KEY EXECUTIVES
TABLE 75. CREATIVE ENZYMES TECHNOLOGIES, LLC: COMPANY SNAPSHOT
TABLE 76. CREATIVE ENZYMES TECHNOLOGIES, LLC: OPERATING SEGMENTS
TABLE 77. CREATIVE ENZYMES TECHNOLOGIES, LLC: PRODUCT PORTFOLIO
TABLE 78. CREATIVE ENZYMES TECHNOLOGIES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. MP BIOMEDICALS: KEY EXECUTIVES
TABLE 80. MP BIOMEDICALS: COMPANY SNAPSHOT
TABLE 81. MP BIOMEDICALS: OPERATING SEGMENTS
TABLE 82. MP BIOMEDICALS: PRODUCT PORTFOLIO
TABLE 83. MP BIOMEDICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. RANDOX LABORATORIES LIMITED: KEY EXECUTIVES
TABLE 85. RANDOX LABORATORIES LIMITED: COMPANY SNAPSHOT
TABLE 86. RANDOX LABORATORIES LIMITED: OPERATING SEGMENTS
TABLE 87. RANDOX LABORATORIES LIMITED: PRODUCT PORTFOLIO
TABLE 88. RANDOX LABORATORIES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89. SEKISUI DIAGNOSTICS: KEY EXECUTIVES
TABLE 90. SEKISUI DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 91. SEKISUI DIAGNOSTICS: OPERATING SEGMENTS
TABLE 92. SEKISUI DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 93. SEKISUI DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. PROSPEC-TANY TECHNOGENE LTD.: KEY EXECUTIVES
TABLE 95. PROSPEC-TANY TECHNOGENE LTD.: COMPANY SNAPSHOT
TABLE 96. PROSPEC-TANY TECHNOGENE LTD.: OPERATING SEGMENTS
TABLE 97. PROSPEC-TANY TECHNOGENE LTD.: PRODUCT PORTFOLIO
TABLE 98. PROSPEC-TANY TECHNOGENE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 100. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 101. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 102. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 103. ROCHE DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. WORTHINGTON BIOCHEMICAL CORPORATION: KEY EXECUTIVES
TABLE 105. WORTHINGTON BIOCHEMICAL CORPORATION: COMPANY SNAPSHOT
TABLE 106. WORTHINGTON BIOCHEMICAL CORPORATION: OPERATING SEGMENTS
TABLE 107. WORTHINGTON BIOCHEMICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 108. WORTHINGTON BIOCHEMICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL ALCOHOL DEHYDROGENASE MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ALCOHOL DEHYDROGENASE MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ALCOHOL DEHYDROGENASE MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALALCOHOL DEHYDROGENASE MARKET
FIGURE 10. GLOBAL ALCOHOL DEHYDROGENASE MARKET SEGMENTATION, BY TYPE
FIGURE 11. ALCOHOL DEHYDROGENASE MARKET FOR MEDIUM-CHAIN ENZYMES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ALCOHOL DEHYDROGENASE MARKET FOR SHORT-CHAIN ENZYMES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GLOBAL ALCOHOL DEHYDROGENASE MARKET SEGMENTATION, BY APPLICATION
FIGURE 14. ALCOHOL DEHYDROGENASE MARKET FOR ALCOHOL CONCENTRATION DETECTION, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ALCOHOL DEHYDROGENASE MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. ALCOHOL DEHYDROGENASE MARKET FOR CATALYST, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 21. COMPETITIVE DASHBOARD
FIGURE 22. COMPETITIVE HEATMAP: ALCOHOL DEHYDROGENASE MARKET
FIGURE 23. TOP PLAYER POSITIONING, 2023
FIGURE 24. SIGMA-ALDRICH: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. SIGMA-ALDRICH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. SIGMA-ALDRICH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. THERMO FISHER SCIENTIFIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. BIOVISION INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. BIOVISION INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. BIOVISION INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. CREATIVE ENZYMES TECHNOLOGIES, LLC: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. CREATIVE ENZYMES TECHNOLOGIES, LLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. CREATIVE ENZYMES TECHNOLOGIES, LLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. MP BIOMEDICALS: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. MP BIOMEDICALS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. MP BIOMEDICALS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. RANDOX LABORATORIES LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. RANDOX LABORATORIES LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. RANDOX LABORATORIES LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SEKISUI DIAGNOSTICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. SEKISUI DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SEKISUI DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. PROSPEC-TANY TECHNOGENE LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. PROSPEC-TANY TECHNOGENE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. PROSPEC-TANY TECHNOGENE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. ROCHE DIAGNOSTICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. ROCHE DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. WORTHINGTON BIOCHEMICAL CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. WORTHINGTON BIOCHEMICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. WORTHINGTON BIOCHEMICAL CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)

Companies Mentioned

  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • BioVision Inc.
  • Creative Enzymes Technologies, LLC
  • MP Biomedicals
  • Randox Laboratories Limited
  • Sekisui Diagnostics
  • Prospec-Tany Technogene Ltd.
  • Roche Diagnostics
  • worthington biochemical corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information